Skip to main content
. 2008 Jun 13;105(24):434–440. doi: 10.3238/arztebl.2008.0434

Figure 3.

Figure 3

Gender- and age-adjusted prevalence rates for adenoma (green) and advanced adenoma/carcinoma (red) among screening participants (Scr), patients with fecal occult blood (Mic), patients with macroscopic bleeding (Mac), patients undergoing adenoma surveillance (Ad), patients undergoing carcinoma follow-up (Ca), and patients with other clinical signs and symptoms (Cs)